Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

WIMM Professor Ahmed Ahmed, along with Martin Drysdale from the Beatson Institute in Glasgow and Stefan Knapp (TDI, Oxford) have been awarded a substantial DPFS (Developmental Pathway Funding Scheme) grant (~£1.9M) from the MRC.  The grant will support intensive medicinal chemistry efforts, structural biology and preclinical evaluation to develop novel small molecule inhibitor of SIK2 for ovarian cancer therapy.

ahmed_ahmed

 

Similar stories

Ahmed group closer to finding the cell of origin for ovarian cancer

Obs and Gyn

New research brings the Ahmed group closer to finding the cell of origin of ovarian cancer, and their ultimate aim of developing a much-needed screening tool for ovarian cancer.

New grant to tackle the immune response to ovarian cancer

MRC HIU Obs and Gyn RDM

Many congratulations to Prof Ahmed Ahmed and Prof Enzo Cerundolo, winners of the Ovarian Cancer Action International Grand Challenge Award.

Understanding the origins of ovarian cancer

Obs and Gyn

Research into the early detection of ovarian cancer by the Ahmed group at the MRC WIMM receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

MRC WIMM researchers win prestigious national awards

MRC HIU MRC MHU RDM

Congratulations to Prof Graham Ogg and Prof Paresh Vyas who have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. This is a tremendous achievement as these are highly competitive and prestigious awards.

Defining the role of lipids in skin inflammation

MRC HIU RDM

Congratulations to Prof Graham Ogg who has been awarded a Wellcome Trust Collaborative Award to investigate aspects of the immune response in skin diseases such as eczema, with the hope of identifying new treatment options.

New international collaborative network to study β-thalassaemia

MRC MHU RDM

A new grant from the UK Academy of Medical Sciences will allow clinicians and scientists from Oxford, Sri Lanka and Thailand to establish new ties to support research into β thalassaemia and benefit those most affected.